|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 564.94 USD | -0.74% |
|
-0.96% | +15.94% |
| 05-07 | United Therapeutics Insider Sold Shares Worth $5,600,468, According to a Recent SEC Filing | MT |
| 05-07 | United Therapeutics Insider Sold Shares Worth $4,870,054, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 596.76 | 596.76 | 588.38 |
| Spread/Res. | -5.33% | -5.33% | -3.98% |
| Spread/Supp. | +0.95% | +8.39% | +37.79% |
| Support | 559.65 | 521.22 | 410 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition